Skip to content

Precigen PGEN Available for sale investments

Available for sale investments at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
BridgeBio Pharma logo
BridgeBio PharmaBBIO
Amgen logo
AmgenAMGN
Merck & Co. logo
Merck & Co.MRK

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$1.91B+213%
Enterprise value$2B+234%
P/S72×

Profitability

See full
Gross margin83.6%
Operating margin-2,890.9%
Net margin-3,656%
FCF margin-1,756.5%

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×
Current ratio4.8×+1.3×

Where this comes from

Reported directly by Precigen in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecurities.

The official record: Precigen’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Precigen's available for sale investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Precigen's available for sale investments?
Precigen (PGEN) reported available for sale investments of $49.26M in Q1 2026.
How has Precigen's available for sale investments changed year-over-year?
Precigen's available for sale investments decreased by 34.3% year-over-year, from $74.93M to $49.26M.
What is the long-term trend for Precigen's available for sale investments?
Over 5 years (2020 to 2025), Precigen's available for sale investments has grown at a 7.7% compound annual growth rate (CAGR), from $48.33M to $70.14M.